Cargando…
Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in vitro imm...
Autores principales: | Li, Matthew, Khong, Danika, Chin, Ling-Yee, Singleton, Amy, Parekkadan, Biju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931547/ https://www.ncbi.nlm.nih.gov/pubmed/29717209 http://dx.doi.org/10.1038/s41598-018-24971-2 |
Ejemplares similares
-
Dynamics of Ex Vivo Mesenchymal Stromal Cell Potency under Continuous Perfusion
por: Doshi, Aneesha, et al.
Publicado: (2023) -
Image-Based Profiling of Patient-Derived Pancreatic Tumor–Stromal Cell
Interactions Within a Micropatterned Tumor Model
por: Mukundan, Shilpaa, et al.
Publicado: (2018) -
Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application
por: O'Rourke, Brian, et al.
Publicado: (2021) -
A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation
por: Elman, Jessica S, et al.
Publicado: (2014) -
Pharmacokinetics of Natural and Engineered Secreted Factors Delivered by Mesenchymal Stromal Cells
por: Elman, Jessica S., et al.
Publicado: (2014)